Evidence map›Paper›PMID 36011033›Full record

ArticleCancers2022

Real-World Data on Newly Diagnosed

Marta Bini, Stanislas Quesada, Pierre Meeus, Manuel Rodrigues, Eric Leblanc, Anne Floquet, Patricia Pautier, Frédéric Marchal, Magali Provansal, Loïc Campion and 15 more

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03275298 (Epidemiological Strategy and Medical Economic), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03275298 suspendednot on this map

Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Database : Evolution of the Therapeutic Care in Ovarian Cancer Across the French Comprehensive Cancer Centers From 2011

TypeobservationalSponsorUNICANCERRan2017 to 2026Enrolled13,331ConditionsOvarian Cancer
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 19 institutions in 2 countries.

Marta BiniCentre Léon Bérard, 69008 Lyon, France.
Stanislas QuesadaCentre Léon Bérard, 69008 Lyon, France.ORCID 0000-0001-6338-9306
Pierre MeeusCentre Léon Bérard, 69008 Lyon, France.
Manuel RodriguesInstitut Curie, 75005 Paris, France.ORCID 0000-0002-5443-0802
Eric LeblancCentre Oscar Lambret, 59000 Lille, France.ORCID 0000-0001-7299-0339
Anne FloquetInstitut Bergonié, 33076 Bordeaux, France.
Patricia PautierGustave Roussy, 94805 Villejuif, France.ORCID 0000-0002-1459-268X
Frédéric MarchalInstitut de Cancérologie de Lorraine, 54519 Vandœuvre-lès-Nancy, France.
Magali ProvansalInstitut Paoli Calmettes, 13009 Marseille, France.
Loïc CampionInstitut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.ORCID 0000-0003-4903-0908
Sylvain CauseretCentre Georges Francois Leclerc, 21000 Dijon, France.
Sophie GourgouInstitut Régional du Cancer de Montpellier, 34298 Montpellier, France.
Isabelle Ray-CoquardCentre Léon Bérard, 69008 Lyon, France.ORCID 0000-0003-2472-8306
Jean-Marc ClasseDepartment of Surgery, Institut de Cancerologie de l'Ouest, Boulevard Professor Monod, 44805 Saint Herblain, France.ORCID 0000-0002-6167-5832
Christophe PomelCentre Jean Perrin, 63011 Clermont-Ferrand, France.
Thibault De La Motte RougeCentre Eugene Marquis, 35000 Rennes, France.
Emmanuel BarrangerCentre Antoine Lacassagne, 06100 Nice, France.
Aude Marie SavoyeInstitut Godinot, 51726 Reims, France.
Cécile GuillemetCentre Henri Becquerel, 76038 Rouen, France.
Laurence GladieffInstitut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France.
Martin DemarchiInstitut de Cancérologie Strasbourg ICANS, 67200 Strasbourg, France.
Roman RouzierCentre François Baclesse, 14000 Caen, France.
C CourtinardUnicancer, 75654 Paris, France.
Clémence RomeoCentre Léon Bérard, 69008 Lyon, France.ORCID 0000-0003-1280-8069
Florence JolyCentre François Baclesse, 14000 Caen, France.
Centre Léon Bérard · FRCentre François Baclesse · FRInstitut de Cancérologie de l'Ouest · FRCentre Antoine Lacassagne · FRCentre Eugène Marquis · FRCentre Georges François Leclerc · FRCentre Henri BecquerelCentre Jean Perrin · FRCentre Oscar Lambret · FRInstitut Bergonié · FRInstitut Claudius Regaud · FRInstitut Curie · FRInstitut de Cancérologie de Lorraine · FRInstitut de Cancérologie Strasbourg · FRInstitut de Recherche en Cancérologie de Montpellier · FRInstitut Gustave Roussy · FRInstitut Jean Godinot · FRInstitut Pprime · FRUniCancer Group · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn spite of the frequency and clinical impact of

methodsConsecutive patients with

resultsOut of the 8021 patients included in the ESME database, 266 patients matching the selection criteria were included.

conclusionsThis study reports the largest French multicenter cohort of

Indexed as

BRCA1BRCA2epidemiological strategy and medical economics databaseepidemiologyhigh-grade epithelial ovarian canceroverall survivalplatinum-based chemotherapyprogression-free survivalreal-world datatreatment patterns

Identifiers

PMID36011033
PMCPMC9406396
OpenAlexW4292547915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.